Skip to main content

Longitudinal monitoring of 4t1-tumor physiology in vivo with doxorubicin treatment via diffuse optical spectroscopy

Publication ,  Journal Article
Vishwanath, K; Yuan, H; Moore, L; Bender, J; Dewhirst, M; Ramanujam, N
Published in: Biomedical Optics, BIOMED 2008
January 1, 2008

A diffuse optical spectrometer was used to monitor 4T1 breast carcinoma tumors implanted in mice. Animals treated with doxorubicin showed relative increased oxygen saturation and decreased blood volume vs. Controls, over a 10 day period. © 2008 Optical Society of America.

Duke Scholars

Published In

Biomedical Optics, BIOMED 2008

DOI

Publication Date

January 1, 2008
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Vishwanath, K., Yuan, H., Moore, L., Bender, J., Dewhirst, M., & Ramanujam, N. (2008). Longitudinal monitoring of 4t1-tumor physiology in vivo with doxorubicin treatment via diffuse optical spectroscopy. Biomedical Optics, BIOMED 2008. https://doi.org/10.1364/biomed.2008.btuc3
Vishwanath, K., H. Yuan, L. Moore, J. Bender, M. Dewhirst, and N. Ramanujam. “Longitudinal monitoring of 4t1-tumor physiology in vivo with doxorubicin treatment via diffuse optical spectroscopy.” Biomedical Optics, BIOMED 2008, January 1, 2008. https://doi.org/10.1364/biomed.2008.btuc3.
Vishwanath K, Yuan H, Moore L, Bender J, Dewhirst M, Ramanujam N. Longitudinal monitoring of 4t1-tumor physiology in vivo with doxorubicin treatment via diffuse optical spectroscopy. Biomedical Optics, BIOMED 2008. 2008 Jan 1;
Vishwanath, K., et al. “Longitudinal monitoring of 4t1-tumor physiology in vivo with doxorubicin treatment via diffuse optical spectroscopy.” Biomedical Optics, BIOMED 2008, Jan. 2008. Scopus, doi:10.1364/biomed.2008.btuc3.
Vishwanath K, Yuan H, Moore L, Bender J, Dewhirst M, Ramanujam N. Longitudinal monitoring of 4t1-tumor physiology in vivo with doxorubicin treatment via diffuse optical spectroscopy. Biomedical Optics, BIOMED 2008. 2008 Jan 1;

Published In

Biomedical Optics, BIOMED 2008

DOI

Publication Date

January 1, 2008